BACK TO ALL

MATTHEW PORTEUS, M.D., PH.D.

Porteus uses genome editing as curative therapy for genetic diseases, as exemplified by his correction of the mutation in sickle cell disease in hematopoietic stem and progenitor cells. He is now combining genome editing with synthetic biology to engineer cells having new phenotypic properties, such as engineering resistance to HIV and enhancing wound healing.

Photo of MATTHEW PORTEUS, M.D., PH.D.